España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Cannabidiol
Rachel Sennott Arrested In Cayman Islands: I Wanted 'To Be Arrested For Something Awesome' Not CBD
CBD Nutraceuticals Market Set For Explosive Growth, Projected To Reach $29.1B By 2030
CBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics?
CBD Nutraceuticals Market Set For Explosive Growth, Projected To Reach $29.1B By 2030
CBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics?
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
CBD May Enhance Running Experience By Lowering Anxiety, Study Suggests
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
CBD May Enhance Running Experience By Lowering Anxiety, Study Suggests
Can CBD Help With Alcohol Use Disorder? New Scientific Review Finds There's Something To It
This Pharma Company Is Working With Israeli Medical Center To Research And Treat Autism With CBD
Read More...
Cannabidiol Recent News
ICYMI: When David Crosby Talked Exploratory Weed Brand, CBD As A Painkiller With Benzinga
This story was originally published in September 2018. As perhaps the world’s most identifiable hippie, David Crosby says his face belongs on a package of pot. The 77-year-old singer-songwriter is pursuing a cannabis licensing opportunity under the working name “Mighty Croz.”
Lexaria Announces DehydraTECH-CBD Versus Prescription CBD Program In Treating Seizures
CbdMD Net Sales Revenue Expected To Spike 76%, According To Prelim Report
Cannabidiol brand cbdMD Inc. (NYSE: YCBD) anticipates generating between $41.7 million and $41.8 million in net sales revenue in the fourth quarter of this fiscal year.
After Bellator, Barstool And GNC Deals, cbdMD Has 'High Hopes' For Life Time Partnership
CbdMD Inc. (NYSE: YCBD) has signed a multi-year retail distribution agreement with health club chain Life Time Inc. (LT). CbdMD’s cannabidiol products will be available for sale in Life Time's physical locations as well as its online store.
Curious About CBD? This Startup Pledges To Help You Navigate 'Saturated Market'
CBD, or cannabidiol, is often touted as a panacea despite a lack of research and market saturation, according to Miraculo Inc. CEO Michael Klein.
God's Greenery CEO Cites CBD Boom Among Christians, Prepares Product Rollout
Last month, cannabidiol residue was discovered on two historic altars — currently housed in the Israel Museum, Jerusalem.
Exclusive: Ad Agency PrograMetrix And NisonCo Confirm Cannabis, CBD Partnership
Seattle-based programmatic advertising agency PrograMetrix and New Jersey-based public relations firm NisonCo have finalized a formal partnership to widen their shared range of services available to both companies’ rosters of cannabis and CBD industry clients, Benzinga has learned.
Cannabis Industry Alliance To Explore CBD's Liver Effects
Clinical research and data firm ValidCare LLC is joining major CBD companies on an industrywide studying focusing on the effects cannabidiol has on the liver.
CbdMD's Stock Rises 80% After Net Quarterly Sales Spike YoY Reaching $9.4M
Cannabidiol brand CbdMD Inc. (NYSE: YCBD) announced that net quarterly sales boosted 67% on a year-over-year basis, reaching $9.4 million.
For Mother's Day, This Cannabis Doctor Wants Common Sense Legislation
Cannabis companies are hustling to stay afloat and turn a profit just like every other business, but for Dr. Chanda Macias, the ramifications of the economic downturn are much more personal.
TeaLief Maker To Acquire Medicinal Mushroom Company
FDA Grants GW Pharmaceuticals Priority Review For Cannabidiol Drug In Seizure Condition
GW Pharma Submits CBD Seizure Treatment To European Medicines Agency For Approval
Avicanna Imports Colombian CBD Isolates Into Canada For Scientific Research
EFSA's CBD Novel Food Classification
FDA Says It Will Evaluate Cannabis Scientifically
Cannabis Still Can't Be Sold, Promoted On Facebook Or Instagram
How This CBD Company Is Tackling A New Market: 'It's Important To Be First'
The CBD Pet Edibles Market Shows Room For Growth, Improvement
Nano-Cap Life On Earth's Stock Surges Following CBD Beverage Announcement
Hemp Is Getting So Popular Even The WWE Championship Belt Is Now Made Out Of It
What Is CBD — And How Can Investors Take Advantage Of It?
2 Cannabis Stocks Becoming Popular Short-Seller Targets